Chinese Journal of Chromatography ›› 2026, Vol. 44 ›› Issue (5): 547-554.DOI: 10.3724/SP.J.1123.2025.08023
• Articles • Previous Articles Next Articles
LIANG Jing, FENG Jiali, ZENG Dong, ZHOU Liping, ZHONG Xuan, LI Yi, CHEN Dongyang(
)
Received:2025-08-29
Online:2026-05-08
Published:2026-05-07
Supported by:CLC Number:
LIANG Jing, FENG Jiali, ZENG Dong, ZHOU Liping, ZHONG Xuan, LI Yi, CHEN Dongyang. Determination of perfluorinated compounds, antibiotics and pesticides in drinking water by automated solid phase extraction with ultra-performance liquid chromatography-tandem mass spectrometry[J]. Chinese Journal of Chromatography, 2026, 44(5): 547-554.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chrom-china.com/EN/10.3724/SP.J.1123.2025.08023
| No. | Compound | Abbreviation | ESI | Parent ion (m/z) | Product ions (m/z) | CEs/eV | CV/V |
|---|---|---|---|---|---|---|---|
| 1 | carbaryl (甲奈威) | + | 202.1 | 145.0*, 127.0 | 10, 25 | 30 | |
| 2 | atrazine (莠去津) | + | 216.1 | 174.0*, 132.0 | 25, 18 | 30 | |
| 3 | bentazone (灭草松) | - | 239.2 | 132.1*, 197.2 | 20, 20 | 30 | |
| 4 | 2,4-dichlorophenoxyacetic acid (2,4-二氯苯氧乙酸) | 2,4-D | - | 218.8 | 161.0*, 125.0 | 10, 18 | 30 |
| 5 | carbofuran (克百威) | + | 222.1 | 165.1*, 123.0 | 12, 12 | 20 | |
| 6 | sarafloxacin (沙拉沙星) | + | 386.2 | 342.3*, 299.0 | 25, 38 | 30 | |
| 7 | danofloxacin (达氟沙星) | + | 358.3 | 340.2*, 314.0 | 26,18 | 30 | |
| 8 | lomefloxacin (洛美沙星) | + | 352.0 | 265.2*, 308.1 | 32, 23 | 30 | |
| 9 | pefloxacin (培氟沙星) | + | 334.2 | 290.1*, 316.1 | 29, 25 | 30 | |
| 10 | metoxuron (甲氧隆) | + | 229.0 | 72.0*, 156.0 | 28, 20 | 30 | |
| 11 | triflumuron (杀铃脲) | - | 357.1 | 176.0*, 153.9 | 30, 27 | 30 | |
| 12 | chlorantraniliprole (氯虫苯甲酰胺) | - | 482.0 | 204.0*, 202.0 | 20, 27 | 30 | |
| 13 | teflubenzuron (氟苯脲) | - | 379.1 | 195.9*, 358.8 | 29, 9 | 30 | |
| 14 | chlorfluazuron (氟啶脲) | - | 539.9 | 520.1*, 356.6 | 15, 28 | 30 | |
| 15 | lufenuron (氟丙氧脲) | - | 509.1 | 325.9*, 175.0 | 27, 50 | 30 | |
| 16 | flufurazone (氟虫脲) | - | 487.0 | 467.0*, 156.3 | 9, 21 | 30 | |
| 17 | perfluorodecanoic acid (全氟癸酸) | PFDA | - | 513.0 | 469.0*, 219.0 | 18, 18 | 30 |
| 18 | perfluorononanoic acid (全氟壬酸) | PFNA | - | 463.0 | 419.0*, 219.0 | 16, 14 | 30 |
| 19 | perfluorooctanoic acid (全氟辛酸) | PFOA | - | 413.0 | 369.0*, 169.0 | 12, 24 | 30 |
| 20 | perfluoroheptanoic acid (全氟庚酸) | PFHpA | - | 363.0 | 319.0*, 169.0 | 14, 24 | 30 |
| 21 | perfluorohexanoic acid (全氟己酸) | PFHxA | - | 312.9 | 269.0*, 119.0 | 10, 20 | 14 |
| 22 | perfluorobutanesulfonic acid (全氟丁烷磺酸) | PFBS | - | 299.0 | 80.0*, 99.0 | 30, 28 | 30 |
| 23 | perfluorohexanesulfonic acid (全氟己烷磺酸) | PFHxS | - | 398.8 | 79.8*, 98.9 | 38, 34 | 30 |
| 24 | perfluorodecanesulfonic acid sodium (全氟癸烷磺酸) | PFDS | - | 599.0 | 80.0*, 99.0 | 30, 28 | 30 |
| 25 | perfluorooctane sulfonic acid (全氟辛烷磺酸) | PFOS | - | 499.0 | 99.0*, 80.0 | 28, 30 | 30 |
| 26 | perfluoroundecanoic acid (全氟十一酸) | PFUnDA | - | 563.0 | 519.0*, 319.0 | 16, 28 | 30 |
| 27 | perfluorododecanoic acid (全氟十二酸) | PFDoDA | - | 613.0 | 569.0*, 169.0 | 18, 36 | 30 |
| 28 | perfluorotridecanoic acid (全氟十三酸) | PFTrDA | - | 633.0 | 619.0*, 169.0 | 20, 38 | 30 |
| 29 | perfluorotetradecanoic acid (全氟十四酸) | PFTeDA | - | 713.0 | 669.0*, 169.0 | 20, 38 | 30 |
| 30 | perfluorohexadecanoic acid (全氟十六酸) | PFHxDA | - | 813.0 | 769.0*, 169.0 | 18, 30 | 30 |
Table 1 MRM MS parameters of the 30 compounds
| No. | Compound | Abbreviation | ESI | Parent ion (m/z) | Product ions (m/z) | CEs/eV | CV/V |
|---|---|---|---|---|---|---|---|
| 1 | carbaryl (甲奈威) | + | 202.1 | 145.0*, 127.0 | 10, 25 | 30 | |
| 2 | atrazine (莠去津) | + | 216.1 | 174.0*, 132.0 | 25, 18 | 30 | |
| 3 | bentazone (灭草松) | - | 239.2 | 132.1*, 197.2 | 20, 20 | 30 | |
| 4 | 2,4-dichlorophenoxyacetic acid (2,4-二氯苯氧乙酸) | 2,4-D | - | 218.8 | 161.0*, 125.0 | 10, 18 | 30 |
| 5 | carbofuran (克百威) | + | 222.1 | 165.1*, 123.0 | 12, 12 | 20 | |
| 6 | sarafloxacin (沙拉沙星) | + | 386.2 | 342.3*, 299.0 | 25, 38 | 30 | |
| 7 | danofloxacin (达氟沙星) | + | 358.3 | 340.2*, 314.0 | 26,18 | 30 | |
| 8 | lomefloxacin (洛美沙星) | + | 352.0 | 265.2*, 308.1 | 32, 23 | 30 | |
| 9 | pefloxacin (培氟沙星) | + | 334.2 | 290.1*, 316.1 | 29, 25 | 30 | |
| 10 | metoxuron (甲氧隆) | + | 229.0 | 72.0*, 156.0 | 28, 20 | 30 | |
| 11 | triflumuron (杀铃脲) | - | 357.1 | 176.0*, 153.9 | 30, 27 | 30 | |
| 12 | chlorantraniliprole (氯虫苯甲酰胺) | - | 482.0 | 204.0*, 202.0 | 20, 27 | 30 | |
| 13 | teflubenzuron (氟苯脲) | - | 379.1 | 195.9*, 358.8 | 29, 9 | 30 | |
| 14 | chlorfluazuron (氟啶脲) | - | 539.9 | 520.1*, 356.6 | 15, 28 | 30 | |
| 15 | lufenuron (氟丙氧脲) | - | 509.1 | 325.9*, 175.0 | 27, 50 | 30 | |
| 16 | flufurazone (氟虫脲) | - | 487.0 | 467.0*, 156.3 | 9, 21 | 30 | |
| 17 | perfluorodecanoic acid (全氟癸酸) | PFDA | - | 513.0 | 469.0*, 219.0 | 18, 18 | 30 |
| 18 | perfluorononanoic acid (全氟壬酸) | PFNA | - | 463.0 | 419.0*, 219.0 | 16, 14 | 30 |
| 19 | perfluorooctanoic acid (全氟辛酸) | PFOA | - | 413.0 | 369.0*, 169.0 | 12, 24 | 30 |
| 20 | perfluoroheptanoic acid (全氟庚酸) | PFHpA | - | 363.0 | 319.0*, 169.0 | 14, 24 | 30 |
| 21 | perfluorohexanoic acid (全氟己酸) | PFHxA | - | 312.9 | 269.0*, 119.0 | 10, 20 | 14 |
| 22 | perfluorobutanesulfonic acid (全氟丁烷磺酸) | PFBS | - | 299.0 | 80.0*, 99.0 | 30, 28 | 30 |
| 23 | perfluorohexanesulfonic acid (全氟己烷磺酸) | PFHxS | - | 398.8 | 79.8*, 98.9 | 38, 34 | 30 |
| 24 | perfluorodecanesulfonic acid sodium (全氟癸烷磺酸) | PFDS | - | 599.0 | 80.0*, 99.0 | 30, 28 | 30 |
| 25 | perfluorooctane sulfonic acid (全氟辛烷磺酸) | PFOS | - | 499.0 | 99.0*, 80.0 | 28, 30 | 30 |
| 26 | perfluoroundecanoic acid (全氟十一酸) | PFUnDA | - | 563.0 | 519.0*, 319.0 | 16, 28 | 30 |
| 27 | perfluorododecanoic acid (全氟十二酸) | PFDoDA | - | 613.0 | 569.0*, 169.0 | 18, 36 | 30 |
| 28 | perfluorotridecanoic acid (全氟十三酸) | PFTrDA | - | 633.0 | 619.0*, 169.0 | 20, 38 | 30 |
| 29 | perfluorotetradecanoic acid (全氟十四酸) | PFTeDA | - | 713.0 | 669.0*, 169.0 | 20, 38 | 30 |
| 30 | perfluorohexadecanoic acid (全氟十六酸) | PFHxDA | - | 813.0 | 769.0*, 169.0 | 18, 30 | 30 |
| Compound | Linear range/(μg/L) | Linear equation | r | LOD/(ng/L) | LOQ/(ng/L) |
|---|---|---|---|---|---|
| Carbaryl | 0.10-100.0 | y=1392.7x+126.5 | 0.997 | 0.1 | 0.30 |
| Atrazine | 0.10-50.0 | y=119359x+952.1 | 0.999 | 0.01 | 0.030 |
| Bentazone | 0.10-200.0 | y=1303.2x+38.5 | 0.998 | 0.5 | 1.5 |
| 2,4-D | 0.50-100.0 | y=605.14x+82.2 | 0.999 | 0.8 | 2.4 |
| Carbofuran | 0.10-50.0 | y=123892x+6276.3 | 0.997 | 0.01 | 0.030 |
| Sarafloxacin | 0.10-100.0 | y=5209.8x-854.9 | 0.998 | 0.02 | 0.060 |
| Danofloxacin | 0.50-100.0 | y=3506.329x-2547.4 | 0.992 | 0.1 | 0.30 |
| Lomefloxacin | 0.10-100.0 | y=12655.6x-1385.6 | 0.995 | 0.1 | 0.30 |
| Pefloxacin | 0.10-100.0 | y=7935.2x-1517.0 | 0.994 | 0.1 | 0.30 |
| Metoxuron | 0.10-100.0 | y=68770.8x+28480.0 | 0.995 | 0.1 | 0.30 |
| Triflumuron | 0.50-200.0 | y=186.7x-27.7 | 0.993 | 1 | 3.0 |
| Chlorantraniliprole | 0.50-200.0 | y=825.1x+121.7 | 0.997 | 0.5 | 1.5 |
| Teflubenzuron | 0.50-200.0 | y=505.5x-125.2 | 0.997 | 0.5 | 1.5 |
| Chlorfluazuron | 0.50-200.0 | y=2489.7x-694.3 | 0.997 | 0.3 | 0.90 |
| Lufenuron | 0.50-200.0 | y=1363.3x-601.4 | 0.991 | 0.3 | 0.90 |
| Flufurazone | 0.50-200.0 | y=515.7x-110.6 | 0.990 | 0.7 | 2.1 |
| PFDA | 0.50-100.0 | y=1157.3x+523.8 | 0.995 | 0.2 | 0.60 |
| PFNA | 0.50-100.0 | y=1330.6x+594.8 | 0.990 | 0.2 | 0.60 |
| PFOA | 0.50-100.0 | y=1872.6x+3260.8 | 0.995 | 0.2 | 0.60 |
| PFHpA | 0.50-100.0 | y=377.4x+209.2 | 0.997 | 0.5 | 1.5 |
| PFHxA | 0.50-100.0 | y=2135.1x+539.8 | 0.991 | 0.2 | 0.60 |
| PFBS | 0.50-100.0 | y=3962.3x+292.5 | 0.999 | 0.2 | 0.60 |
| PFHxS | 0.50-100.0 | y=11351.5x+1017.1 | 0.999 | 0.1 | 0.30 |
| PFDS | 0.50-100.0 | y=354.4x-6.3 | 0.992 | 0.5 | 1.5 |
| PFOS | 0.50-100.0 | y=2657.5x+1240.0 | 0.990 | 0.2 | 0.60 |
| PFUnDA | 0.50-100.0 | y=2646.3x-111.0 | 0.999 | 0.2 | 0.60 |
| PFDoDA | 0.50-100.0 | y=1601.9x-595.0 | 0.994 | 0.3 | 0.90 |
| PFTrDA | 0.50-100.0 | y=797.9x-328.5 | 0.997 | 0.5 | 1.5 |
| PFTeDA | 0.50-100.0 | y=4735.5x-662.2 | 0.997 | 0.2 | 0.60 |
| PFHxDA | 0.50-100.0 | y=4769.8x-1813.0 | 0.992 | 0.2 | 0.60 |
Table 2 Linear ranges, linear equations, correlation coefficients ( r ), LODs and LOQs of the 30 compounds
| Compound | Linear range/(μg/L) | Linear equation | r | LOD/(ng/L) | LOQ/(ng/L) |
|---|---|---|---|---|---|
| Carbaryl | 0.10-100.0 | y=1392.7x+126.5 | 0.997 | 0.1 | 0.30 |
| Atrazine | 0.10-50.0 | y=119359x+952.1 | 0.999 | 0.01 | 0.030 |
| Bentazone | 0.10-200.0 | y=1303.2x+38.5 | 0.998 | 0.5 | 1.5 |
| 2,4-D | 0.50-100.0 | y=605.14x+82.2 | 0.999 | 0.8 | 2.4 |
| Carbofuran | 0.10-50.0 | y=123892x+6276.3 | 0.997 | 0.01 | 0.030 |
| Sarafloxacin | 0.10-100.0 | y=5209.8x-854.9 | 0.998 | 0.02 | 0.060 |
| Danofloxacin | 0.50-100.0 | y=3506.329x-2547.4 | 0.992 | 0.1 | 0.30 |
| Lomefloxacin | 0.10-100.0 | y=12655.6x-1385.6 | 0.995 | 0.1 | 0.30 |
| Pefloxacin | 0.10-100.0 | y=7935.2x-1517.0 | 0.994 | 0.1 | 0.30 |
| Metoxuron | 0.10-100.0 | y=68770.8x+28480.0 | 0.995 | 0.1 | 0.30 |
| Triflumuron | 0.50-200.0 | y=186.7x-27.7 | 0.993 | 1 | 3.0 |
| Chlorantraniliprole | 0.50-200.0 | y=825.1x+121.7 | 0.997 | 0.5 | 1.5 |
| Teflubenzuron | 0.50-200.0 | y=505.5x-125.2 | 0.997 | 0.5 | 1.5 |
| Chlorfluazuron | 0.50-200.0 | y=2489.7x-694.3 | 0.997 | 0.3 | 0.90 |
| Lufenuron | 0.50-200.0 | y=1363.3x-601.4 | 0.991 | 0.3 | 0.90 |
| Flufurazone | 0.50-200.0 | y=515.7x-110.6 | 0.990 | 0.7 | 2.1 |
| PFDA | 0.50-100.0 | y=1157.3x+523.8 | 0.995 | 0.2 | 0.60 |
| PFNA | 0.50-100.0 | y=1330.6x+594.8 | 0.990 | 0.2 | 0.60 |
| PFOA | 0.50-100.0 | y=1872.6x+3260.8 | 0.995 | 0.2 | 0.60 |
| PFHpA | 0.50-100.0 | y=377.4x+209.2 | 0.997 | 0.5 | 1.5 |
| PFHxA | 0.50-100.0 | y=2135.1x+539.8 | 0.991 | 0.2 | 0.60 |
| PFBS | 0.50-100.0 | y=3962.3x+292.5 | 0.999 | 0.2 | 0.60 |
| PFHxS | 0.50-100.0 | y=11351.5x+1017.1 | 0.999 | 0.1 | 0.30 |
| PFDS | 0.50-100.0 | y=354.4x-6.3 | 0.992 | 0.5 | 1.5 |
| PFOS | 0.50-100.0 | y=2657.5x+1240.0 | 0.990 | 0.2 | 0.60 |
| PFUnDA | 0.50-100.0 | y=2646.3x-111.0 | 0.999 | 0.2 | 0.60 |
| PFDoDA | 0.50-100.0 | y=1601.9x-595.0 | 0.994 | 0.3 | 0.90 |
| PFTrDA | 0.50-100.0 | y=797.9x-328.5 | 0.997 | 0.5 | 1.5 |
| PFTeDA | 0.50-100.0 | y=4735.5x-662.2 | 0.997 | 0.2 | 0.60 |
| PFHxDA | 0.50-100.0 | y=4769.8x-1813.0 | 0.992 | 0.2 | 0.60 |
| Compound | 0.20 μg/L | 1.0 μg/L | 10.0 μg/L | Compound | 0.20 μg/L | 1.0 μg/L | 10.0 μg/L | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rec./% | RSD/% | Rec./% | RSD/% | Rec./% | RSD/% | Rec./ % | RSD/% | Rec./ % | RSD/% | Rec./ % | RSD/% | ||
| Carbaryl | 72.5 | 4.9 | 71.3 | 4.0 | 75.9 | 6.7 | Flufurazone | 76.3 | 9.4 | 80.3 | 8.2 | 78.2 | 7.5 |
| Atrazine | 75.2 | 8.1 | 76.7 | 6.7 | 72.4 | 5.4 | PFDA | 107.4 | 9.6 | 115.4 | 6.2 | 85.7 | 6.8 |
| Bentazone | 115.0 | 6.2 | 70.4 | 5.3 | 76.2 | 5.1 | PFNA | 120.0 | 9.1 | 71.4 | 6.0 | 116.1 | 6.7 |
| 2,4-D | 120.0 | 8.7 | 80.5 | 6.5 | 77.1 | 6.3 | PFOA | 119.6 | 8.7 | 118.9 | 8.9 | 81.4 | 8.1 |
| Carbofuran | 105.0 | 5.3 | 76.4 | 4.7 | 73.4 | 6.7 | PFHpA | 115.8 | 8.5 | 81.7 | 7.4 | 71.1 | 4.9 |
| Sarafloxacin | 90.2 | 7.9 | 119.7 | 7.2 | 106.3 | 7.2 | PFHxA | 78.5 | 8.6 | 119.5 | 7.2 | 75.4 | 7.8 |
| Danofloxacin | 115.0 | 8.1 | 76.4 | 4.7 | 86.5 | 6.4 | PFBS | 110.5 | 7.6 | 70.4 | 3.4 | 72.6 | 6.3 |
| Lomefloxacin | 83.3 | 3.5 | 78.6 | 5.5 | 90.1 | 5.2 | PFHxS | 107.5 | 3.2 | 117.4 | 9.1 | 78.3 | 9.1 |
| Pefloxacin | 85.4 | 8.3 | 119.4 | 5.7 | 75.4 | 7.5 | PFDS | 70.3 | 8.4 | 71.5 | 3.6 | 76.7 | 8.5 |
| Metoxuron | 90.1 | 6.0 | 76.7 | 7.6 | 73.2 | 9.3 | PFOS | 115.7 | 6.3 | 110.2 | 6.5 | 72.8 | 8.4 |
| Triflumuron | 75.7 | 7.6 | 118.7 | 4.6 | 112.4 | 8.1 | PFUnDA | 118.3 | 6.5 | 75.4 | 5.9 | 113.4 | 7.6 |
| Chlorantraniliprole | 90.0 | 8.7 | 70.6 | 7.4 | 72.3 | 7.5 | PFDoDA | 70.2 | 8.1 | 70.5 | 4.7 | 77.4 | 7.9 |
| Teflubenzuron | 120.0 | 8.6 | 71.2 | 8.9 | 76.7 | 6.9 | PFTrDA | 70.8 | 9.5 | 83.5 | 9.2 | 85.6 | 5.7 |
| Chlorfluazuron | 74.2 | 9.5 | 73.4 | 7.8 | 112.2 | 8.6 | PFTeDA | 75.4 | 8.8 | 116.6 | 8.4 | 71.5 | 4.2 |
| Lufenuron | 70.8 | 6.9 | 71.7 | 3.6 | 77.5 | 7.4 | PFHxDA | 80.6 | 6.9 | 119.2 | 7.6 | 115.4 | 6.8 |
Table 3 Recoveries and relative standard deviations of the 30 compounds at different spiked levels (n=6)
| Compound | 0.20 μg/L | 1.0 μg/L | 10.0 μg/L | Compound | 0.20 μg/L | 1.0 μg/L | 10.0 μg/L | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rec./% | RSD/% | Rec./% | RSD/% | Rec./% | RSD/% | Rec./ % | RSD/% | Rec./ % | RSD/% | Rec./ % | RSD/% | ||
| Carbaryl | 72.5 | 4.9 | 71.3 | 4.0 | 75.9 | 6.7 | Flufurazone | 76.3 | 9.4 | 80.3 | 8.2 | 78.2 | 7.5 |
| Atrazine | 75.2 | 8.1 | 76.7 | 6.7 | 72.4 | 5.4 | PFDA | 107.4 | 9.6 | 115.4 | 6.2 | 85.7 | 6.8 |
| Bentazone | 115.0 | 6.2 | 70.4 | 5.3 | 76.2 | 5.1 | PFNA | 120.0 | 9.1 | 71.4 | 6.0 | 116.1 | 6.7 |
| 2,4-D | 120.0 | 8.7 | 80.5 | 6.5 | 77.1 | 6.3 | PFOA | 119.6 | 8.7 | 118.9 | 8.9 | 81.4 | 8.1 |
| Carbofuran | 105.0 | 5.3 | 76.4 | 4.7 | 73.4 | 6.7 | PFHpA | 115.8 | 8.5 | 81.7 | 7.4 | 71.1 | 4.9 |
| Sarafloxacin | 90.2 | 7.9 | 119.7 | 7.2 | 106.3 | 7.2 | PFHxA | 78.5 | 8.6 | 119.5 | 7.2 | 75.4 | 7.8 |
| Danofloxacin | 115.0 | 8.1 | 76.4 | 4.7 | 86.5 | 6.4 | PFBS | 110.5 | 7.6 | 70.4 | 3.4 | 72.6 | 6.3 |
| Lomefloxacin | 83.3 | 3.5 | 78.6 | 5.5 | 90.1 | 5.2 | PFHxS | 107.5 | 3.2 | 117.4 | 9.1 | 78.3 | 9.1 |
| Pefloxacin | 85.4 | 8.3 | 119.4 | 5.7 | 75.4 | 7.5 | PFDS | 70.3 | 8.4 | 71.5 | 3.6 | 76.7 | 8.5 |
| Metoxuron | 90.1 | 6.0 | 76.7 | 7.6 | 73.2 | 9.3 | PFOS | 115.7 | 6.3 | 110.2 | 6.5 | 72.8 | 8.4 |
| Triflumuron | 75.7 | 7.6 | 118.7 | 4.6 | 112.4 | 8.1 | PFUnDA | 118.3 | 6.5 | 75.4 | 5.9 | 113.4 | 7.6 |
| Chlorantraniliprole | 90.0 | 8.7 | 70.6 | 7.4 | 72.3 | 7.5 | PFDoDA | 70.2 | 8.1 | 70.5 | 4.7 | 77.4 | 7.9 |
| Teflubenzuron | 120.0 | 8.6 | 71.2 | 8.9 | 76.7 | 6.9 | PFTrDA | 70.8 | 9.5 | 83.5 | 9.2 | 85.6 | 5.7 |
| Chlorfluazuron | 74.2 | 9.5 | 73.4 | 7.8 | 112.2 | 8.6 | PFTeDA | 75.4 | 8.8 | 116.6 | 8.4 | 71.5 | 4.2 |
| Lufenuron | 70.8 | 6.9 | 71.7 | 3.6 | 77.5 | 7.4 | PFHxDA | 80.6 | 6.9 | 119.2 | 7.6 | 115.4 | 6.8 |
| Compound | Sample Nos. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
| Carbaryl | - | - | 0.2 | - | - | - | - | - | - |
| Atrazine | 1.0 | 0.3 | 9.7 | 1.2 | 0.4 | 2.7 | 0.7 | 2.1 | 0.6 |
| Bentazone | - | - | - | - | 1.0 | - | - | - | - |
| 2,4-D | 3.3 | 5.8 | - | - | 1.8 | - | - | 1.9 | - |
| Carbofuran | 0.2 | - | 0.2 | - | 0.1 | - | - | 0.1 | - |
| Sarafloxacin | - | - | - | - | - | - | 0.3 | - | - |
| Danofloxacin | - | - | - | 3.9 | - | - | - | - | - |
| Pefloxacin | - | - | - | - | - | - | 2.1 | 2.4 | 2.0 |
| Chlorantra-niliprole | 8.6 | 5.3 | 2.7 | 9.9 | 4.5 | 1.5 | 8.5 | - | 0.8 |
| PFDA | 1.0 | - | - | - | 0.3 | 0.3 | - | - | - |
| PFNA | - | - | 0.4 | - | - | 0.3 | 0.3 | - | 1.4 |
| PFOA | 2.3 | - | 3.9 | 4.5 | 2.3 | - | 3.1 | 3.3 | 4.6 |
| PFHxA | - | - | 0.8 | 0.3 | - | - | 0.4 | - | - |
| PFUnDA | - | - | 0.4 | - | - | - | - | - | 0.3 |
| PFTrDA | - | - | - | 0.7 | - | 0.5 | - | - | 0.5 |
| PFTeDA | - | - | - | 0.6 | - | - | - | - | - |
Table 4 Test results of actual water samples
| Compound | Sample Nos. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
| Carbaryl | - | - | 0.2 | - | - | - | - | - | - |
| Atrazine | 1.0 | 0.3 | 9.7 | 1.2 | 0.4 | 2.7 | 0.7 | 2.1 | 0.6 |
| Bentazone | - | - | - | - | 1.0 | - | - | - | - |
| 2,4-D | 3.3 | 5.8 | - | - | 1.8 | - | - | 1.9 | - |
| Carbofuran | 0.2 | - | 0.2 | - | 0.1 | - | - | 0.1 | - |
| Sarafloxacin | - | - | - | - | - | - | 0.3 | - | - |
| Danofloxacin | - | - | - | 3.9 | - | - | - | - | - |
| Pefloxacin | - | - | - | - | - | - | 2.1 | 2.4 | 2.0 |
| Chlorantra-niliprole | 8.6 | 5.3 | 2.7 | 9.9 | 4.5 | 1.5 | 8.5 | - | 0.8 |
| PFDA | 1.0 | - | - | - | 0.3 | 0.3 | - | - | - |
| PFNA | - | - | 0.4 | - | - | 0.3 | 0.3 | - | 1.4 |
| PFOA | 2.3 | - | 3.9 | 4.5 | 2.3 | - | 3.1 | 3.3 | 4.6 |
| PFHxA | - | - | 0.8 | 0.3 | - | - | 0.4 | - | - |
| PFUnDA | - | - | 0.4 | - | - | - | - | - | 0.3 |
| PFTrDA | - | - | - | 0.7 | - | 0.5 | - | - | 0.5 |
| PFTeDA | - | - | - | 0.6 | - | - | - | - | - |
|
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||